Safety, tolerability, and efficacy of orally administered atogepant for the prevention of episodic migraine in adults: a double-blind, randomised phase 2b/3 trial
| Autor: | Goadsby, Peter J *, Dodick, David W, Ailani, Jessica, Trugman, Joel M, Finnegan, Michelle, Lu, Kaifeng, Szegedi, Armin |
|---|---|
| Zdroj: | In The Lancet Neurology September 2020 19(9):727-737 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|